Having more bacteria-fighting immune cells in the nose and throat may explain why some people are more likely to be infected by respiratory viruses.
Oct 09, 2020
0
159
As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.
Sep 25, 2020
0
1
(HealthDay)—Yet another rapid COVID-19 test has proven its mettle in spotting infection with the new coronavirus, this time in a British study.
Sep 18, 2020
0
2
Finland declared a lockdown in response to the coronavirus pandemic in March 2020, and the ensuing social distancing measures decreased the number of pediatric emergency room visits to nearly one-third of what they used to ...
Aug 17, 2020
0
16
(HealthDay)—Nirsevimab prevents respiratory syncytial virus (RSV)-associated lower respiratory tract infections in healthy preterm infants, while maternal RSV fusion (F) protein nanoparticle vaccination did not meet the ...
Jul 30, 2020
0
2
A study from Ann & Robert H. Lurie Children's Hospital of Chicago discovered that children younger than 5 years with mild to moderate COVID-19 have much higher levels of genetic material for the virus in the nose compared ...
Jul 30, 2020
0
102
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
Jul 09, 2020
0
1392
Researchers at UConn's Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published ...
Jun 17, 2020
0
63
"At what point do knowledge and questioning become pessimism?"
Jun 11, 2020
0
3
As SARS-CoV-2 has the potential to mutate, it is important to check the efficacy of current diagnostic tests, say York University researchers, who found seven out of 27 methods had potential sequence mismatch issues that ...
Jun 10, 2020
0
154
Human respiratory syncytial virus (RSV) causes respiratory tract infections. It is the major cause of lower respiratory tract infection and hospital visits during infancy and childhood. There is no vaccine, and the only treatment is oxygen.
In temperate climates there is an annual epidemic during the winter months. In tropical climates, infection is most common during the rainy season.
In the United States, 60% of infants are infected during their first RSV season, and nearly all children will have been infected with the virus by 2-3 years of age. Natural infection with RSV does not induce protective immunity, and thus people can be infected multiple times. Sometimes an infant can become symptomatically infected more than once even within a single RSV season. Severe RSV infections have increasingly been found among elderly patients.
RSV is a negative-sense, single-stranded RNA virus of the family Paramyxoviridae, which includes common respiratory viruses such as those causing measles and mumps. RSV is a member of the paramyxovirus subfamily Pneumovirinae. Its name comes from the fact that F proteins on the surface of the virus cause the cell membranes on nearby cells to merge, forming syncytia.
This text uses material from Wikipedia, licensed under CC BY-SA
